Search
Displaying 541–550 of 684 for “retinal diseases”
-
Leber Congenital Amaurosis Research Advances
Research NewsRecent developments in research on Leber congenital amaurosis.
-
About Page
The Foundation Fighting Blindness Brand Ambassador Program empowers passionate individuals affected by blinding diseases to share their stories, raise awareness, and inspire action in the fight against vision loss. Together, we’re amplifying voices and accelerating our path to treatments and cures.
-
Ocugen Launches Phase 2/3 Clinical Trial for Stargardt Disease Gene-Modifier Therapy
Research NewsThe therapy delivers copies of the RORA gene to address multiple disease pathways.
-
Want to support this historic event? Sponsorship and exhibitor opportunities are available for organizations, foundations, and industry partners dedicated to advancing retinal research and innovation. Learn more by sending an email to Partnerships@FightingBlindness.org.
-
Eye on the Cure Podcast | Episode 86: Lenore von Krusenstiern, MD, PhD
Eye on the CureDr. Lenore von Krusenstiern talks about Bluerock’s clinical trial for a photoreceptor replacement therapy for people with inherited retinal conditions such as retinitis pigmentosa and cone-rod dystrophy.
-
Research News
The company is planning a Phase 2/3 clinical trial for the therapy in late 2025.
-
Mental Health Advisory Council
The Foundation Fighting Blindness mental health initiative is guided by a mental health advisory council (MHAC) which includes five expert therapists (four of whom are blind or have low vision), a retinal specialist who has treated patients facing severe depression and anxiety, and a Foundation Board Member affected by vision loss who organized a local mental health support group.
-
Eye on the Cure Podcast | Episode 78: Dr. Sheldon Rowan
Eye on the CureDr. Rowan talks about the impact of the glycemic index, microbiome, and diet on the development of age-related macular degeneration and optimization of overall retinal health.
-
Share Your Vision: Heather Edwards
Beacon StoriesHeather Edwards has turned her personal journey with cone-rod dystrophy into a mission to support others facing similar challenges. Despite facing difficulties during her youth, Heather now uses her experiences to advocate for awareness and support for blinding diseases, emphasizing that blindness is a spectrum and each person’s experience is uniquely valuable.
-
Research News
The Phase 3 trial is expected to begin in Q1 2025
.png)
